Luminex Licenses miRNA IP from MIT to Develop and Sell Assays

genomeweb
360dx

Luminex Licenses miRNA IP from MIT to Develop and Sell Assays

Feb 28, 2006

NEW YORK, Feb. 28 (GenomeWeb News) - Luminex has taken a non-exclusive license from the Massachusetts Institute of Technology to develop and commercialize miRNA assays.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Genedrive Receives UK NIHR Grant for Antibiotic-Related Hearing Loss Assay
MBS, Intas Science Imaging Instruments Sign Distribution Deal for Thermal Cycler in Germany
Pancreatic Cancer Risk Linked to Germline Mutations in Six Cancer Predisposition Genes
MS Risk Linked to HLA Haplotype Mediated by Altered Methylation
Genetic Technologies, Swisstec Reach Deal on JV
Grifols Gets FDA Clearance for Two Blood Screening Assays on Procleix Panther System

The Scan

Dual Listings Sought

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

Allocating the Grant Pie

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

More Proposed for NSF

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

This Week in PNAS

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.

Main menu